Survivin: A novel marker and potential therapeutic target for human angiosarcoma.
Tsuneki M, Kinjo T, Mori T, Yoshida A, Kuyama K, Ohira A, Miyagi T, Takahashi K, Kawai A, Chuman H, Yamazaki N, Masuzawa M, Arakawa H.
Tsuneki M, et al. Among authors: mori t.
Cancer Sci. 2017 Nov;108(11):2295-2305. doi: 10.1111/cas.13379. Epub 2017 Sep 15.
Cancer Sci. 2017.
PMID: 28845553
Free PMC article.